You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 11, November 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Medical Education
 •Medical Ethics
 •Ophthalmology, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Continuing Medical Education, Physicians, and Pavlov

Can We Change What Happens When Industry Rings the Bell?

Paul R. Lichter, MD

Arch Ophthalmol. 2008;126(11):1593-1597.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

"The traditional independence of physicians and the welfare of the public are being threatened by the new vogue among drug manufacturers to promote their products by assuming an aggressive role in the ‘education’ of doctors."1 Although written nearly half a century ago, this comment is worth considering today, especially as it pertains to continuing medical education (CME).

We commonly invoke CME to mean something good and something needed. In many ways, we seem to respond to it with a conditioned, Pavlovian response. Continuing medical education helps assure us and our patients that we are up to date in a fast-changing medical environment. The number of CME offerings grows annually. Yet, while it grows, much has transpired in the CME field to turn it on its head. Physician-industry relationships in CME have led to a creeping skepticism about how CME is planned and financed. Questions are being . . . [Full Text of this Article]

CME'S BEGINNINGS


EVOLUTION OF THE CME INDUSTRY

CME ACCREDITATION AND MANDATES

WHO PAYS FOR CME?

INDUSTRY ADAPTS ITS GIFT-GIVING APPROACH

THE EXPANSION OF CME AND INDUSTRY'S INVOLVEMENT

MEDICAL EDUCATION SERVICE SUPPLIERS

STOKING PHYSICIANS’ CME INSTINCTS

WHAT CAN BE DONE?

CHANGING THE PICTURE

EXAMPLE OF A VIRTUOUS ORGANIZATION

CONCLUSIONS

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Perspective on Commercial Relationships Between Ophthalmology and Industry
Jampol et al.
Arch Ophthalmol 2009;127:1194-1202.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.